Navigation Links
SEC in Medical News

UCI Medical Affiliates, Inc.'s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer

COLUMBIA, S.C., July 8 /PRNewswire-FirstCall/ -- UCI Medical Affiliates, Inc. (UCIA.PK) announced that on July 6, 2009, the Securities and Exchange Commission filed a Complaint in the United States District Court for the District of South Carolina against Jerry F. Wells, Jr., the former Executive ...

Report: Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Preventing Honest Disclosures

Investor Environmental Health Network Analysis Finds Disturbing Asbestos-Nanotech Parallels That Could Saddle Investors with a Major New Round of Costly Mega-Litigation WASHINGTON, June 16 /PRNewswire-USNewswire/ -- Billions of dollars in potential asbestos-like litigation risks for nanotechn...

MyMedicalRecords, Inc. Stand-Alone Audited Financial Statements for the Period Ending December 31, 2008 to be Filed with the SEC Today, Monday, May 4, 2009

LOS ANGELES, May 4 /PRNewswire-FirstCall/ -- MMR Information Systems, Inc. (OTC Bulletin Board: MMRF), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (collectively, "MMR") provides consumer-controlled Personal Health Records ("PHRs") ( www.mymedicalrecords.com ) and ...

MedQuist Announces Resolution of SEC Investigation

MOUNT LAUREL, N.J., March 13 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ ), a leading provider of medical transcription services, is pleased to announce that it has resolved the investigation by the Securities and Exchange Commission (SEC) regarding the Company's historic billing pract...

Santa Monica Media Corporation Files Extension Proxy With SEC to Complete Transaction

SANTA MONICA, Calif., March 6 /PRNewswire-FirstCall/ -- On March 5, 2009, Santa Monica Media Corporation (NYSE Alternext US: MEJ, MEJ.U, MEJ.WS) ("SMMC"), a special purpose acquisition company (SPAC) that completed its IPO in April 2007 filed a preliminary proxy statement with the Securities Excha...

Rodobo International, Inc. Files Fiscal Year 2008 SEC Form 10-K

HARBIN, China, Jan. 13 /PRNewswire-Asia-FirstCall/ -- Rodobo International, Inc. (OTC Bulletin Board: RDBO) filed its Annual Report on Form 10-K for its fiscal year ended September 30, 2008 today. Key highlights from the financial results of the fiscal year ended September 30, 2008 include: ...

OrthoSynetics(TM) Applauds SEC Suit Against Former Company Management

New Management Cleaning Up 'Legacy Issues'; Cites New Company's Leadership Team, Safeguards METAIRIE, La., Feb 13 /PRNewswire/ -- OrthoSynetics(TM), the largest provider of business services to orthodontic and dental practices worldwide, today lauded the Securities an...

Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter

Former CEO Agrees to Forego $420 Million in Compensation and Benefits MINNEAPOLIS, Dec. 6 /PRNewswire-USNewswire/ -- Former CEO and Chairman of UnitedHealth Group Corporation, Dr. William McGuire, today agreed to terms with the UnitedHealth Special Litigation Committee (SLC) that call for ...

MedQuist Updates Status of Outstanding SEC Filings

MT. LAUREL, N.J., Sept. 28 /PRNewswire-FirstCall/ -- MedQuist Inc. (Pink Sheets: MEDQ.PK) today announced that it is nearing completion of the work on its Forms 10-Q for the first two quarters of 2007 and expects filing both reports with the Securities and Exchange Commission (SEC) by the midd...

CareFusion Files Amended Form 10 Registration Statement With SEC

SAN DIEGO, July 7 /PRNewswire-FirstCall/ -- CareFusion Corporation, the company that will become public from the planned spinoff of Cardinal Health's clinical and medical products businesses, today filed a fourth amendment to its Form 10 Registration Statement with the Securities and Exchange Comm...

More>>

SEC in Medical Technology

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

...by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in the public filings with the sec and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in san...

Covance Receives Highest Level of Phase I Accreditation

...ations in more than 25 countries, and more than 10,000 employees worldwide. Information on Covance's products and services, recent press releases, and sec filings can be obtained through its website at www.covance.com . Statements contained in this press release, which are not historical facts,...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

...arly trials may not be repeated in later trials, and Rigel's need for additional capital, as well as other risks detailed from time to time in Rigel's sec reports, including its Form 10-Q for the quarter ended March 31, 2009. Rigel does not undertake any obligation to update forward-looking statements. ...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

...markets the Companies serve. Actual results may differ materially from these forward-looking statements due to a number of factors. See the Companies' sec filings, and in particular, the risk factors described in their Annual Reports on Form 10-K and their most recent report on Form 10-Q. The Companies d...

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

...on Amylin, Lilly and/or Alkermes. These and additional risks and uncertainties are described more fully in Amylin's, Lilly's and Alkermes' most recent sec filings including their Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K. Amylin, Lilly and Alkermes undertake no duty to update these f...

CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series

...f the Company's potential products, inability to raise the necessary capital and the risk factors set forth from time to time in CEL-SCI Corporation's sec filings, including but not limited to its report on Form 10- K/A for the year ended September 30, 2008. The Company undertakes no obligation to public...

Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial

...ise in the clinical testing and approval process and Rigel's need for additional capital, as well as other risks detailed from time to time in Rigel's sec reports, including its Form 10-Q for the quarter ended March 31, 2009. Rigel does not undertake any obligation to update forward-looking statements. ...

5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH

...essful, the future approval and commercial success of therapeutic alternatives as well as those discussed or identified in the public filings with the sec and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in...

Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech

...ty of Sangamo and its collaborators to develop commercially viable products and technological developments by our competitors. See the company's sec filings, and in particular, the risk factors described in the company's Annual Report on Form 10-K and its most recent Quarterly Report on Form 10-Q. ...

Sanofi-aventis Stands Behind the Safety of Lantus(R)

...essful, the future approval and commercial success of therapeutic alternatives as well as those discussed or identified in the public filings with the sec and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in...

More>>

SEC in Medical Products

AliQuot

Description: Maximize Sample Recovery with The aliquot! The aliquot from Genetix is a low volume non-contact liquid dispenser compatible with 96, 384, and 1536 well microplates. With its accuracy, versatility, fast dispensing action, backfilling facility and optional microplate stacker, the aliquot is the compl...
Company:Genetix

Multi RF

Description:...ow pitch 62 dBA quiet operation, quick accel 30-60 sec to set speed, quick decel 30-60 sec to open cover, convenient rcf run control, At-Speed timer mode times run down from set speed in 1 sec increments, Re-Run control for accumulated centrif...
Company:ThermoFisher Scientific

Randot Stereo Smile Test II

Description:... Stereo Smile II also includes a blank card and tests at 60, 120, 240 and 480 sec of arc. Smile Test II Includes: 1 demonstration card 1 pair pediatric 3-D viewers 1 pair infant 3-D viewers...
Company:Stereo Optical Company

Randot Stereo Smile Test

Description:... Smile Tests at 480 and 120 sec of arc The Smile Tests are designed for children of 6 months to 5 years of age, or any non- verbal patient Stereo Smile Tests screen for: ...
Company:Stereo Optical Company

Randot® Preschool Stereoacuity Test

Description:...ght. Randot Preschool includes 3 test booklets: Book #1: 200 & 100 sec of arc Book #2: 60 & 40 sec of arc...
Company:Stereo Optical Company

Stereo Butterfly SO-005

Description:...rception for Both Gross Stereopsis (2500 to 1200 sec of arc) and Fine Depth Perception. The Test Includes: Graded Circle Test (800 to 40 sec of arc) An Animal Test for Children (400 to 100 sec of arc) 1 Pair of Standard 3-D Viewers...
Company:Stereo Optical Company

Randot SO-002

Description:...ception from Random Dot Backgrounds (500 and 250 sec of arc). The Test Includes: Graded Circle Test (400 to 20 sec of arc) An Animal Test for Children (400 to 100 sec of arc) 1 Pair of Standard 3-D Viewers...
Company:Stereo Optical Company

Stereo Fly SO-001

Description:...tion. Test and Evaluate Both Gross (2500 to 1200 sec or arc) and Fine Depth Perception. The Test Includes: Graded Circle Test (800 to 40 sec of arc) Animal Test for Children (400 to 100 sec of arc) 1 Pair of Standard 3-D Viewers...
Company:Stereo Optical Company

M700 Automated Perimeter

Features:...5 x 3dB steps / 45 x 1dB steps Stimulus Duration - Adjustable 0.1 to 9.9 sec (nom. 0.2 sec) Minimum Inter-stimulus Delay - Adjustable 0.1 to 9.9 sec (nom. 0.4 sec) Background Illumination - 10 asb (3.2cd/m), automatic lev...
Company:Medmont Pty. Ltd.

CoaguChek S

Features:...every box of test strips, for easy system calibration All values, even those stored in memory, can be obtained in any of the formats INR, % Quick, sec or Ratio, by a simple menu-guided procedure Automatic display of test results, either as single values or, if desired, in two formats simultaneous...
Company:Roche Diagnostics

More>>

SEC in Biological News

Stinger Systems, Inc. Settles With the SEC

TAMPA, Fla., May 1 /PRNewswire-FirstCall/ -- Stinger Systems, Inc. (OTC Bulletin Board: STIY), a leader in electro-stun technology today announced that it had reached a settlement agreement with the Securities and Exchange Commission. Stinger Systems, Inc. said it settled the matter without ...

Aware, Inc. Amends and Extends Dutch Auction Tender Offer

...ing Amendment No. 1 and Amendment No. 2 (the "Schedule TO"), filed with the sec in connection with the tender offer. The Offer to Purchase, the Letter of T...der offer documents filed with the SEC) have been or will be filed with the sec and will be available at no charge on the SEC's web site, www.sec.gov , ...

Aware, Inc. Amends and Extends Dutch Auction Tender Offer

...ing Amendment No. 1 and Amendment No. 2 (the "Schedule TO"), filed with the sec in connection with the tender offer. The Offer to Purchase, the Letter of T...der offer documents filed with the SEC) have been or will be filed with the sec and will be available at no charge on the SEC's web site, www.sec.gov , ...

UniPixel Announces Availability of Opcuity(TM) Finger Print Resistant Film Test Samples

...the other various disclosures in the Company's Annual Report on Form 10 for the year ended December 31, 2008, as well as other public filings with the sec since such date. For further information contact: Uni-Pixel, Inc. Investor Relations: Laura Guerrant-Oiye Guerrant Associates ...

CEL-SCI Corporation to Launch Aseptic Filling for Stem Cell Produced Therapies and Other Biological Products

..., inability to raise the necessary capital to achieve the planned objectives and the risk factors set forth from time to time in CEL-SCI Corporation's sec filings, including but not limited to its report on Form 10-K/A for the year ended September 30, 2008. The Company undertakes no obligation to publicl...

SAIC Awarded $115 Million Subcontract to Support Tactical Biometrics Systems (TBS)

...the risk factors set forth in SAIC's Annual Report on Form 10-K for the period ended January 31, 2008, and other such filings that SAIC makes with the sec from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which sp...

Anadys Pharmaceuticals to Present at the Roth OC Growth Stock Conference

... results in future clinical trials or will receive regulatory approval. Risk factors that may cause actual results to differ are discussed in Anadys' sec filings, including Anadys' Form 10-K for the year ended December 31, 2007 and Anadys' Form 10-Q for the quarter ended September 30, 2008. All forward...

Global Energy Systems to Acquire WoodTech, LLC, and Affiliated Entities

...e see the sections entitled "Risk Factors" in the company's most recent annual report on Form 10-K and quarterly report on Form 10-Q as filed with the sec The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future results. The company...

U.S. Army Biometrics Task Force Awards Contract to SAIC

...the risk factors set forth in SAIC's Annual Report on Form 10-K for the period ended January 31, 2008, and other such filings that SAIC makes with the sec from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which sp...

Beckman Coulter Updates 2008 Outlook

...Additional factors that could cause actual results to differ are discussed in Part I, Item 1A (Risk Factors) of the Company's Form 10-K filed with the sec on February 29, 2008 as well as in the Company's Form 10-Qs filed since then and reports on Form 8-K that the Company may file from time to time. Fo...

More>>

SEC in Biological Technology

Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock

MONTVALE, N.J., Feb. 24 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (NYSE Alternext US: SYI) today announced that it has entered into agreements with the current holders of its Series B Preferred Stock, $0.01 par value per share, under which $2,875,000 in accrued dividend obligations r...

EESTECH Inc - Release From SEC Filing

LOS ANGELES, Feb. 18 /PRNewswire-FirstCall/ -- The Board of Directors wishes to confirm to Stockholders that at its meeting on February 4, 2009 it resolved to file a Form 15 with effect from February 17, 2009. This initiative does not require the approval of stockholders but in the interests of k...

Northwest Biotherapeutics Settles Class Action Complaint, and SEC Investigation Closed Without Action

BETHESDA, Md., Jan. 8 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBO; AIM: NWBS and NWBT) (the "Company" or "NWBT") announced today settlement of a putative securities class action lawsuit, In re Northwest Biotherapeutics, Inc. Securities Litigation , No. C-...

Former Telomolecular CEO Clarifies SEC Settlement

Former Telomolecular CEO, Matthew Sarad, clarifies the scope and terms of his settlement with the SEC. Case No. 2:08-cv-2252-GEB-DAD. (PRWEB) November 3, 2008 -- Telomolecular, a Rancho Cordova, California Corporation, was formed in 2005 to develop and license new nanot...

Coherent, Inc. Announces Termination of SEC Informal Inquiry

SANTA CLARA, Calif., July 10 /PRNewswire-FirstCall/ -- Coherent, Inc. (Nasdaq: COHR ), today announced that the Securities and Exchange Commission has formally notified the Company that its investigation of Coherent's historical stock option granting practices has been terminated and that it ...

Immucor Settles SEC Investigation

Court Approves Class Action Settlement NORCROSS, Ga., Sept. 28 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD ), the global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that the Securities and Exchange Comm...

Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs

WALTHAM, Mass., Aug. 20 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc. (NYSE: TMO ) announced today that certain executive officers, including Marijn E. Dekkers, president and chief executive officer, are adopting stock- trading programs under Securities and Exchange Commission (SEC)...

Helix BioPharma Form 20-F Registration Statement Declared Effective by SEC

AURORA, Ontario, March 12 /PRNewswire/ -- Helix BioPharma Corp. (TSX, FSE: "HBP") announced that its registration statement on Form 20-F has been declared effective by the U.S. Securities and Exchange Commission ("SEC"). Accordingly, Helix's common shares are now registered with the SEC pursu...

NeoGenomics Files Annual Report on Form 10-KSB with the SEC

Also Announces Change to Unaudited Financial Results Released March 18, 2008 FT. MYERS, Fla., April 15 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it had filed with the Securities and Exchange Commission its annua...

National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC

MOUNTAINSIDE, N.J., Dec. 17 /PRNewswire-FirstCall/ -- National Stem Cell Holding, Inc. (Other OTC: NHGI) today announced that its company information, financial information, quotations and press releases are posted on the OTCIQ, a service of the Pink Sheets. OTCIQ is a secure, web-based port...

More>>

SEC in Biological Definition

Alcohol

...ent and raw material. Other common alcohols Isopropyl alcohol ( sec -propyl alcohol, propan-2-ol, 2-propanol) H 3 C-CH(OH)-CH 3 , or "rubbing a...carbon on the propane chain. Isopropyl alcohol is also occasionally called sec -propyl alcohol. As mentioned above alcohols are classified as primary (1...
Other Tags
(Date:6/29/2015)... ... June 29, 2015 , ... Assurex Health, a ... certain neuropsychiatric and chronic pain conditions, has announced appointments to three key leadership ... Peter Donato, Senior Vice President, Chief Financial Officer; Craig S. Lewis, Senior Vice ...
(Date:6/29/2015)... Fernando Valley, CA (PRWEB) , ... June 29, 2015 , ... ... non-invasive treatments designed to lift and tighten sagging skin. Ulthera is a special treatment ... surgery. Instead, it uses ultrasound technology to gently stimulate collagen production. Ulthera is highly ...
(Date:6/29/2015)... ... , ... The world’s fastest and highest flying production aircraft, the SR-71 Blackbird, ... Virginia. This iconic, supersonic stealth plane will become the focal point of the Museum’s ... ceiling of a historic train station is perhaps one of the most unconventional presentations ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... (Cognizin®) from Kyowa Hakko Bio to French consumers. , The specialized eye health ... oxidative stress caused by free radicals. In addition to Citicoline (Cognizin®), Biomacula provides ...
(Date:6/29/2015)... ... June 29, 2015 , ... Celebrities have many skincare secrets, and ... skin all summer long and beyond. People don’t have to be famous to ... aging process, maintain an even skin tone, avoid breakouts, and take skin health and ...
Breaking Medicine News(10 mins):Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 2Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 3Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:SR-71 Prepares for Flight to Science Museum of Virginia 2Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 2Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 3Health News:Skin Guru Shares Celebrity FACE Secrets For Summer-Proofing The Skin 2Health News:Skin Guru Shares Celebrity FACE Secrets For Summer-Proofing The Skin 3
(Date:6/25/2015)... 2015  TAKE Solutions Ltd., a global business technology ... States Patent and Trademark Office (USPTO) for its "Method ... Solutions, Clinical Accelerators to reduce the time taken to ... standardization without the accelerators), thus reducing time to market. ... At the heart of the patented Clinical Data Standardization ...
(Date:6/24/2015)... , June 24, 2015 Biometry ... with emerging biometric password solution one face in. ... one face in, entering the ... ground-breaking and affordable multifactor-authentication biometric answer to the ... technology, provided in partnership with KeyLemon, one face ...
(Date:6/18/2015)... This report analyzes the worldwide markets for ... Segments, which includes Immunoassay Analyzers and Reagents: Enzyme Immunoassay ... Systems, and Nephelometric Immunoassay Systems. The report provides separate ... , Japan , Europe ... Latin America , and Rest of World. Annual ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Global Immunoassay Systems Market 2Global Immunoassay Systems Market 3Global Immunoassay Systems Market 4Global Immunoassay Systems Market 5Global Immunoassay Systems Market 6Global Immunoassay Systems Market 7Global Immunoassay Systems Market 8Global Immunoassay Systems Market 9Global Immunoassay Systems Market 10Global Immunoassay Systems Market 11Global Immunoassay Systems Market 12Global Immunoassay Systems Market 13Global Immunoassay Systems Market 14Global Immunoassay Systems Market 15Global Immunoassay Systems Market 16Global Immunoassay Systems Market 17Global Immunoassay Systems Market 18Global Immunoassay Systems Market 19Global Immunoassay Systems Market 20Global Immunoassay Systems Market 21Global Immunoassay Systems Market 22Global Immunoassay Systems Market 23Global Immunoassay Systems Market 24Global Immunoassay Systems Market 25Global Immunoassay Systems Market 26Global Immunoassay Systems Market 27Global Immunoassay Systems Market 28Global Immunoassay Systems Market 29
Other Contents